Galapagos NV
GLPG
#4563
Rank
A$3.17 B
Marketcap
A$47.56
Share price
-0.57%
Change (1 day)
13.82%
Change (1 year)

Galapagos NV (GLPG) - Total assets

Total assets on the balance sheet as of September 2025 : A$6.20 Billion

According to Galapagos NV's latest financial reports the company's total assets are A$6.20 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Galapagos NV - Total assets on balance sheet (from 2008 to 2025)

Total assets by year

Year Total assets Change
2024-12-31A$6.91 B-2.14%
2023-12-31A$7.07 B-5.26%
2022-12-31A$7.46 B-8.01%
2021-12-31A$8.11 B-11.3%
2020-12-31A$9.14 B-5.81%
2019-12-31A$9.70 B315.38%
2018-12-31A$2.33 B18.25%
2017-12-31A$1.97 B25.05%
2016-12-31A$1.58 B138.02%
2015-12-31A$0.66 B65.24%
2014-12-31A$0.40 B-9.66%
2013-12-31A$0.44 B48.53%
2012-12-31A$0.29 B46.85%
2011-12-31A$0.20 B-19.69%
2010-12-31A$0.25 B10.81%
2009-12-31A$0.22 B-2.66%
2008-12-31A$0.23 B-5.2%
2007-12-31A$0.24 B-11.49%
2006-12-31A$0.28 B112.51%
2005-12-31A$0.13 B382.48%
2004-12-31A$27.36 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
AstraZeneca
AZN
A$172.31 B 2,677.03%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
A$290.28 B 4,578.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$229.32 B 3,595.81%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
A$201.58 B 3,148.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
A$0.24 B-96.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$126.73 B 1,942.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$60.00 B 867.02%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
A$124.14 B 1,900.72%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
A$195.03 B 3,043.15%๐Ÿ‡บ๐Ÿ‡ธ USA